STAT3 cooperates with the non-canonical NF-κB signaling to regulate pro-labor genes in the human placenta

Placenta
L J YuTodd Rosen

Abstract

Our recent studies have shown that constitutively activated non-canonical RelB/NF-κB2 (p52) in the human placenta positively regulates the pro-labor genes CRH and COX-2. STAT3 regulates NF-κB2 (p100) processing to active p52, and in turn, nuclear activation of RelB/p52, by directly binding to p100/p52 in a variety of cancer cells. In the current study, we tested the hypothesis that STAT3 is involved in regulation of pro-labor genes by associating with RelB/p52 heterodimers in the human placenta. We used a variety of techniques including immunohistochemical staining, gene silencing, ectopic expression, chromatin immunoprecipitation, Western blot, RT-qPCR, and immunofluorescence assays in primary culture of cytotrophoblast and placental tissues. We found that knockdown of STAT3 led to down-regulation of both CRH and COX-2 in a dose-dependent manner. By using chromatin immunoprecipitation, we further showed that interaction of RelB with the CRH or COX-2 gene promoters decreased when STAT3 was depleted. Immunofluorescence demonstrated co-localization of STAT3 with RelB or p100/p52 in both the cytoplasm and nucleus of term cytotrophoblasts. Collectively, these results suggest that STAT3 constitutes part of the RelB/p52-containing ac...Continue Reading

References

May 1, 1995·Nature Medicine·M McLeanR Smith
Sep 12, 1997·Science·J E Darnell
Feb 13, 2001·The Journal of Clinical Investigation·P K Epling-BurnetteT P Loughran
Jul 2, 2002·Reproduction : the Official Journal of the Society for the Study of Fertility·John R G ChallisJohn P Newnham
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·David E Levy, J E Darnell
Oct 11, 2002·The EMBO Journal·H J CoopeS C Ley
Dec 16, 2003·American Journal of Reproductive Immunology : AJRI·Florian M CorvinusUdo R Markert
Feb 18, 2004·Nature Reviews. Cancer·Hua Yu, Richard Jove
Feb 26, 2005·Annals of the New York Academy of Sciences·Amy G BrownJerome F Strauss
Nov 9, 2007·The New England Journal of Medicine·Vassilis TsatsarisFrançois Goffinet
Jan 8, 2008·Lancet·Robert L GoldenbergRoberto Romero

❮ Previous
Next ❯

Citations

Apr 4, 2019·Scientific Reports·Mayra Cruz IthierTodd Rosen
Apr 8, 2017·PloS One·Shavahn C LouxBarry A Ball
Mar 28, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nessrine BellamriLaurent Vernhet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.